A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
Taiho Oncology, Inc.
Taiho Oncology, Inc.
AstraZeneca
Seagen Inc.
Takeda
Taiho Oncology, Inc.
Disc Medicine, Inc
BeOne Medicines
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Beijing InnoCare Pharma Tech Co., Ltd.
Chordia Therapeutics, Inc.
Cullinan Therapeutics Inc.
GluBio Therapeutics Inc.
MacroGenics
medac GmbH
Celgene
Bristol-Myers Squibb
Massive Bio, Inc.
Rigel Pharmaceuticals
Ellipses Pharma
BlossomHill Therapeutics
Ossium Health, Inc.
Hangzhou GluBio Pharmaceutical Co., Ltd.
Servier
Remix Therapeutics
Tr1X, Inc.
JaxBio Ltd
NovaOnco Therapeutics Co., Ltd.
Advanced BioDesign
Ascentage Pharma Group Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Shenzhen TargetRx, Inc.
Edgewood Oncology Inc.
Aurigene Discovery Technologies Limited
Celyad Oncology SA